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Abstract
Background: Mass-migration observed in Peru from the 1970s occurred because of the need to escape from
politically motivated violence and work related reasons. The majority of the migrant population, mostly Andean
peasants from the mountainous areas, tends to settle in clusters in certain parts of the capital and their rural
environment could not be more different than the urban one. Because the key driver for migration was not the
usual economic and work-related reasons, the selection effects whereby migrants differ from non-migrants are
likely to be less prominent in Peru. Thus the Peruvian context offers a unique opportunity to test the effects of
migration.
Methods/Design: The PERU MIGRANT (PEru's Rural to Urban MIGRANTs) study was designed to investigate
the magnitude of differences between rural-to-urban migrant and non-migrant groups in specific CVD risk factors.
For this, three groups were selected: Rural, people who have always have lived in a rural environment; Rural-
urban, people who migrated from rural to urban areas; and, Urban, people who have always lived in a urban
environment.
Discussion: Overall response rate at enrolment was 73.2% and overall response rate at completion of the study
was 61.6%. A rejection form was obtained in 282/323 people who refused to take part in the study (87.3%).
Refusals did not differ by sex in rural and migrant groups, but 70% of refusals in the urban group were males. In
terms of age, most refusals were observed in the oldest age-group (>60 years old) in all study groups. The final
total sample size achieved was 98.9% of the target sample size (989/1000). Of these, 52.8% (522/989) were
females. Final size of the rural, migrant and urban study groups were 201, 589 and 199 urban people, respectively.
Migrant's average age at first migration and years lived in an urban environment were 14.4 years (IQR 10–17) and
32 years (IQR 25–39), respectively.
This paper describes the PERU MIGRANT study design together with a critical analysis of the potential for bias 
and confounding in migrant studies, and strategies for reducing these problems. A discussion of the potential 
advantages provided by the case of migration in Peru to the field of migration and health is also presented.
Published: 8 June 2009
BMC Cardiovascular Disorders 2009, 9:23 doi:10.1186/1471-2261-9-23
Received: 8 April 2009
Accepted: 8 June 2009
This article is available from: http://www.biomedcentral.com/1471-2261/9/23
© 2009 Miranda et al; licensee BioMed Central Ltd. 
This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/2.0), 
which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.BMC Cardiovascular Disorders 2009, 9:23 http://www.biomedcentral.com/1471-2261/9/23
Page 2 of 16
(page number not for citation purposes)
Background
Much of the burden associated with NCDs are the result
of environmental and lifestyle factors including tobacco
consumption and decreased physical activity, and are pre-
ventable [1]. Despite this wealth of information available
in the developed world, it is also clear that contexts are dif-
ferent – for example the impact of tobacco on mortality
differs by geographical region [2] – and that there is an
important research gap between developing and devel-
oped countries on these issues [3].
NCDs kill people at economically and socially productive
ages and kill them mostly in the developing world: 80%
of chronic disease deaths occur in LMIC [4]. As part of this
growing concern with NCDs in LMIC [5], "grand chal-
lenges" for research and policy in this area highlights the
need to study the impact of poverty and urbanization on
NCDs [6]. Urban areas of developing countries are grow-
ing much faster [7], and their populations are larger [8],
and thus, it becomes imperative to more fully understand
the impact of migration on health in these settings.
Migration studies have provided informative findings
related to the evaluation of morbidity and mortality pat-
terns as well as risk factors associated to specific condi-
tions amongst migrant and non-migrant groups [9]. Most
of these findings, however, have been usually derived
from the perspective of international migration. As such,
most migrant studies' findings may bias the understand-
ing of the impact of migration in LMIC where most migra-
tion follows a rural-to-urban pattern.
The picture is complex, since the effect of migration on a
particular outcome varies according to who is migrating,
when they migrate, where they migrate from, where they
migrate to, and what health outcome is measured [9].
Migration is further complicated by the fact that it is not
necessarily a random process; the "selection of migrants"
and the "healthy migrant effect" -or, in some circum-
stances, the unhealthy migrant effect – may influence
health and disease risk [10]. Such concern with migrant's
selection bias dates back to 1938 [11]. Migration due to
economic reasons poses additional difficulties in inter-
preting studies, since those with better health or socio-
economic status could be the ones more likely to "afford"
to migrate. It could, therefore, be argued that migrant
groups are self-selected groups.
Relatively few studies have addressed the impact of rural-
to-urban migration on CVD outcomes in LMIC, e.g. the
Kenyan Luo migration study [12] and the Yi People Study
in China [13], but these were conducted a few decades
ago. Another limitation is that migrants were evaluated
within a short-time frame, usually within 6-months after
migration, and long-term assessments of the impact of
migration are thus not available.
Peru offers a unique opportunity to assess the impact of
migration on health. The patterns of migration in Peru
changed dramatically during the political violence that
occurred in the 1970–1990's period, where approximately
70,000 deaths occurred -79% of them in rural areas [14] –
together with large amounts of displaced people – approx-
imately 120,000 displaced families [15]. Thus, it could be
argued, the mass-migration seen in Peru from 1980s
onwards was largely driven by the need to escape from
politically motivated violence rather than only a migra-
tion for economic reasons: the migrants were not simply
a small self-selected atypical group.
Thus, the PERU MIGRANT study, together with other
ongoing migrant research initiatives in India [16] and
Cameroon [17], aims to provide up-to-date evaluations of
the impact of migration on various health outcomes. The
study design of the PERU MIGRANT study, response rates,
analysis of responders versus non-responders and ascer-
tainment of migration exposure are reported in this paper.
Methods/Design
Objectives
It was hypothesized that the risk of CVD increases follow-
ing migration from rural to urban areas in Peru. The aim
of this study was to ascertain whether or not differences
exist in cardiovascular risk profiles between migrants and
non-migrants as well as the magnitude of such differ-
ences. The following research questions were considered:
i) Is there a difference in specific CVD risk factors in the
rural-to-urban migrant group compared to those who did
not migrate?
Additionally, does the pattern of CVD risk factors in the
migrant population vary by:
ii) length of residence in urban environment?
iii) lifetime exposure to urban environment?
iv) age at first migration?
Study design
Cross-sectional survey of three population-based groups:
i) Rural, people born in Ayacucho who have always have
lived in a rural environment (n = 200); ii) Rural-to-urban
migrants, people born in Ayacucho who migrated from
rural to urban areas and currently living in Lima (n = 600);
and, iii) Urban, who have always lived in an urban envi-
ronment, that is people born and currently living in Lima
(n = 200).BMC Cardiovascular Disorders 2009, 9:23 http://www.biomedcentral.com/1471-2261/9/23
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Setting
Lima, Peru's capital, and Ayacucho. Ayacucho, an Andean
department, was one of the most severely affected areas
during this period of violence [18] – more than 50% of all
deaths occurred in Ayacucho [14]. For the period 1988–
1993, 50.7% of the total emigrants from Ayacucho moved
to Lima, making Ayacucho the leading source of migrants
to Lima [19].
The village of San Jose de Secce, located in the Santillana
district, Huanta province in Ayacucho was selected as the
rural study site (Figure 1). The area called "Las Pampas de
San Juan de Miraflores" in Lima, was selected as the urban
area for the study. Both urban and rural-urban migrant
participants were selected from the Pampas de San Juan de
Miraflores area, a periurban shantytown in the south of
Lima.
Participants
A single-stage random sampling method was used in all
groups. In the case of San Jose de Secce in Ayacucho, a cen-
sus was conducted in mid 2007 to identify all adult pop-
ulation permanently living in the area. The sampling
frame for the urban group was derived from the local cen-
sus, conducted in year 2000. All those who reported to
have been born in Lima in the 2000 census and currently
living permanently in the recorded address were consid-
ered eligible for the study. In the case of the rural-to-urban
migrant group, the same 2000 census was updated in
2006 to identify all those who referred to have been born
Map of Peru and location of study sites in Lima and Ayacucho Figure 1
Map of Peru and location of study sites in Lima and Ayacucho.
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LIMA
AYACUCHO
Pampas de San Juan
(Distrito de 
San Juan de Miraflores)
 San José de Secce
(Distrito de Santillana)BMC Cardiovascular Disorders 2009, 9:23 http://www.biomedcentral.com/1471-2261/9/23
Page 4 of 16
(page number not for citation purposes)
in the department of Ayacucho and were currently living
in Lima.
For all study groups, individuals from both sexes aged 30
years-old and over, permanently living in their residence
were considered eligible. Pregnant women and those with
mental disorders that impair survey completion were
excluded. Participant's selection was stratified by age-
groups and sex to ensure sufficient number of people in
each stratum.
Study variables
Exposures
The primary exposure was migration from a rural to an
urban environment, defined by study group, i.e. rural,
rural-to-urban migrant and urban groups.
To address research questions ii, iii and iv, the migrant
group was subsequently divided by length of residency in
an urban area, lifetime exposure to an urban area, and age
at first migration.
Outcomes
Primary outcomes: blood pressure, prevalence of hyper-
tension, BMI, WHR, prevalence of obesity, fasting glucose,
prevalence of diabetes, total cholesterol and lipoprotein
profile.
Secondary outcomes: behavioral risk factors – alcohol
consumption, smoking status-, inflammation markers –
CRP, fibrinogen-, insulin resistance and metabolic syn-
drome.
Data collection
Questionnaires were constructed after checking relevant
work for the study, including the WHO STEPS [20]. For
the fieldwork, the questionnaires were prepared and
piloted in Spanish [see Additional File 1]. The Spanish
versions of the DHS's Household Assets questionnaire
[21] and CDC's Behavioral Risk Factor Surveillance Sys-
tem Survey Questionnaire [22] were also reviewed as ref-
erence instruments. In addition to the full survey, a
rejection form was also elaborated for non-responders.
A team of community health workers with previous field-
work experience on household visits was trained to enroll
participants and to conduct the questionnaires. All assess-
ments were made at the study coordinating centre by
trained personnel.
Demographic and socioeconomic survey
Age, sex, contact details, place of birth, and proxies of cur-
rent socioeconomic position – educational level, house-
hold income, number of people per room and asset's
possession [23,24] – as well as paternal and maternal edu-
cation levels attained were measured. Socioeconomic
information was aggregated into deprivation indexes to
provide an individual's current socioeconomic depriva-
tion index [25-29].
Migration survey
Information about place of birth (rural or urban), age at
first migration, age at arrival in Lima, education level at
first migration and years lived in urban area were gath-
ered. Lifetime exposure to urban area will be calculated as
number of years lived in an urban area divided over cur-
rent age, and expressed as percentage.
Risk factor survey
Frequency of alcohol consumption in the last year, vol-
ume of alcohol consumption, frequency of hangover in
the last month, smoking status (never, former and cur-
rent), from an adapted version of the WHO STEPS ques-
tionnaires [20], were recorded.
Clinical examination and measurements
Total and sitting height, measured to the nearest 0.1 cm
using a stadiometer and standard stools, and weight, to be
measured with the individual wearing light clothes to the
nearest 0.05 Kg using SECA 940 electronic scale, were part
of the examination.
Skinfolds were measured in triplicate in each measure-
ment site (biceps, triceps, subscapular and suprailiac) to
the nearest 0.2 mm using a Holtain Tanner/Whitehouse
Skinfold Calliper http://www.anthropometer.com/
tw.php. Waist circumference, measured in triplicate at the
midpoint between the lower rib and the iliac crest, and
hip circumference, measured in triplicate at the point
yielding the maximum circumference over the buttocks
were also included. Waist and hip measurements were
made in the horizontal plane, while the participants were
standing, using a tape measure to measure to the nearest
1 cm. For skinfolds, waist and hip circumference, the aver-
age of three measurements was calculated and used in the
analysis.
SBP and DBP were measured using appropriate cuffs for
arm circumference in the sitting position using the right
arm, supported at chest level. Three measurements, at
least 5 min apart using an oscillometric device (Omron
M5-i, Omron, Japan) previously validated for adult popu-
lation [30], were made. Mean of the last two SBP and DBP
measurements were used for the analysis. Hypertension
was considered as SBP ≥ 140 mm Hg or DBP ≥ 90 mm Hg,
or self report of physician diagnosis and currently receiv-
ing antihypertensive medication [31,32].
Laboratory measurements
All laboratory assessments were performed by trained per-
sonnel on venous samples taken in the morning after a
minimum of 8 hours fast.BMC Cardiovascular Disorders 2009, 9:23 http://www.biomedcentral.com/1471-2261/9/23
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Total cholesterol, triglycerides and HDL were measured in
serum. In individuals with triglycerides below 400 mg/dL,
LDL was calculated using the Friedewald equation
[33,34], in mg/dL: LDL = total cholesterol - HDL - (0.2 ×
triglycerides). In individuals with triglycerides greater
than 400 mg/dL, LDL was measured in serum. CRP and
fibrinogen, inflammation markers, were also measured in
serum and plasma, respectively.
Fasting glucose, fasting insulin and glycated hemoglobin
were measured in plasma, serum and whole blood,
respectively. Diabetes was considered as fasting glucose ≥
126 mg/dL (or ≥ 7 mmol/L) [35] or self report of physi-
cian diagnosis and currently receiving antidiabetic medi-
cation. IR was calculated using HOMA calculator (Oxford
Centre for Diabetes, Endocrinology & Metabolism, Diabe-
tes Trials Unit, http://www.dtu.ox.ac.uk/) [36] and
excluding those with diabetes.
Other instruments
The data collected will allow the classification of presence
or absence of metabolic syndrome using various defini-
tions [35,37-39]. In addition, the 12-item General Health
Questionnaire [40] for mental health, a social capital
instrument previously validated in Peru [41], and an
acculturation scale [42] were also applied. Rose angina's
and claudication questionnaire were also used to provide
information about markers of sub-clinical CVD including
peripheral artery disease.
Study size
Power calculations were derived using conservative esti-
mates of the prevalence of major risk factors in the areas
of Huaraz (urban, Andes) and Ingeniería (urban, Lima)
from preliminary work in Peru [43]. The study target was
to recruit a total of 1000 people, i.e. 200 people in each of
the rural and urban groups and 600 migrants.
Comparing the Lima with the Andes group, with 200 peo-
ple in each group, the study had 80% power or greater at
the 5% significance level to detect a difference in the prev-
alence of the following: hypertension 33% versus 19.5%,
power 0.84; and, diabetes 7.6% versus 1.3%, power 0.81.
Statistical methods
The rural group was used as the reference category for the
main analyses. The migration variable will be subse-
quently sub-divided by length of residence in urban envi-
ronment, lifetime exposure to urban area as a proportion
of current age, and age at first migration, and the lowest
categories in each of these will serve as baseline for com-
parisons.
For CVD-related outcomes, only data from all individuals
who complete the study were used in the analysis. Partic-
ipants who completed the study were defined as those
with completed questionnaires, clinical measurements
and laboratory analyses.
Descriptive analysis
For general description of data, frequency analyses will be
calculated as number (percentages), mean (± SD) or
median (IQR) when appropriate. Continuous non-nor-
mally distributed variables will be log transformed if nec-
essary expecting that such logarithm transformation will
lead to normal or near normal distributions. Age- and sex-
adjusted arithmetic means (± SD) or geometric means
(ratios) [44,45] will be presented. In the case of age, since
the study-design only included participants from 30 years-
old or more, a mid/centre age point will be used such that
age 45 years-old will be considered as the baseline in all
age-adjustments when applicable.
Multivariable analysis
Multivariable logistic regression and linear regression will
be used for categorical and continuous outcomes respec-
tively. Adjustment for potential confounding will be
made in a step-wise approach. Adjustment for treatment
effects in specific continuous outcomes, e.g. antihyperten-
sive therapy on blood pressure outcomes, will be pursued
using censored normal regression [46]. In categorical out-
comes, odds ratios and 95% CI will be calculated using
logistic regression. Prevalence ratios will also be calcu-
lated as indicated elsewhere [47].
Standardised mean differences
In the case of continuous outcomes, SMD will be chosen
because of its advantage to interpreting results of continu-
ous data measured with different scales or units, facilitat-
ing comparisons of difference sizes for individual
measures. The Cochrane Collaboration has defined SMD
as "the difference in means between two groups, divided
by the pooled standard deviation of the measurements"
and suggests that "the value of a SMD thus depends on
both the size of the effect (the difference between means)
and the standard deviation of the outcomes (the inherent
variability among participants)" [48].
Due to the lack of units, SMD allows for comparison of
magnitude of differences across various risk factors. In
terms of the interpretation of SMD, the Cochrane Collab-
oration indicates that "rules of thumb exist for interpret-
ing SMD (or 'effect sizes')... 0.2 represents a small effect,
0.5 a moderate effect, and 0.8 a large effect [48,49]".
Ethics
Ethical approval for this protocol was obtained from eth-
ics committees at Universidad Peruana Cayetano Heredia
in Peru and London School of Hygiene and Tropical Med-
icine in the UK. The purpose of the study was explained toBMC Cardiovascular Disorders 2009, 9:23 http://www.biomedcentral.com/1471-2261/9/23
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each of the study participants and informed consent was
obtained, following international standards for ethical
research in developing countries [50,51] [see Additional
File 2 and 3].
Results
Completeness of data
Information was collected from a total of 994 individuals,
and 24/944 (2.4%) had some degree of incomplete infor-
mation in any of the eight study's modules (Table 1).
Being the cardiovascular information the main outcomes
of this study, only participants with completed question-
naires (those people who provided some information to
all sections of the socioeconomic, migration and risk fac-
tors surveys), clinical measurements and laboratory anal-
yses were considered as those who completed study,
totaling 989 participants with completed cardiovascular
data.
Response rates
The final total sample size achieved was 98.9% of the tar-
get sample size (989/1000). Of these, 52.8% (522/989)
were females. Overall response rate at enrolment was
73.2% and overall response rate at completion of the
study was 61.6%. Response rates were higher in the rural
group and lower in the urban group (Table 2). Following
STROBE recommendations for reporting of observational
studies [52], Figure 2, 3 and 4 show numbers of individu-
als at each stage of study and sample attrition in each of
the study groups.
Non-responders
A short rejection form survey was applied to those who
refused to take part in the study gathering basic demo-
graphic and socioeconomic information as well as smok-
ing status, previous diagnosis of hypertension and
diabetes, current treatment for hypertension, age at migra-
Table 1: Survey completeness according to study's modules
Study's modules or questionnaires Number of participants with incomplete modules
n = 944
1. Clinical measurements and laboratory analyses* 4 (0.4%)
2. Socioeconomic questionnaire* 1 (0.1%)
3. Migration questionnaire* 1 (0.1%)
4. Risk factor questionnaire* 3 (0.1%)
5. Physical activity questionnaire 4 (0.4%)
6. Acculturation questionnaire 3 (0.1%)
7. Social capital questionnaire 3 (0.3%)
8. Mental health questionnaire 16 (1.7%)
9. Rose Angina & claudication questionnaire 4 (0.4%)
Missing one module only 12 (1.2%)
Missing two modules 6 (0.6%)
Missing three modules 4 (0.4%)
Missing seven modules 1 (0.1%)
Missing eight modules 1 (0.1%)
Missing any module 24 (2.4%)
Notes: Only data from individuals who completed the modules marked with * were considered as participants with completed cardiovascular data 
(total 989/994). It is expected that missing data will exists in certain specific questions, measurements or laboratory tests for various reasons, but 
this did not disqualify the individual's information to be used on the data analysis process.BMC Cardiovascular Disorders 2009, 9:23 http://www.biomedcentral.com/1471-2261/9/23
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tion and reasons for migration. This form was obtained in
282 people of the total 323 who refused to take part in the
study (87.3%). Male non-responders were more likely to
complete a rejection form (167/282, 59.2%). Among the
different exposure groups, the proportions of non-
responders providing a rejection form were: rural 31/282
(11%) migrants 121/282 (42.9%) and urban 130/282
(46.1%). A breakdown, by age and sex categories and
study group are presented in Figure 5 and 6. A high pro-
portion of refusals were observed in males in the urban
group. In terms of age, most refusals were observed in the
oldest age-group (>60 years old) in all study groups. The
potential bias that these age and sex differences could
have exerted in the main study are controlled, as the final
population studied included similar proportions of sex
and age strata.
Table 3 shows the different reasons provided for refusal to
take part in the study. This was an open-ended question
and responses were aggregated into four main categories.
The most common reason for refusal was accessibility to
social security insurance or access to medical check-ups in
the public health system if necessary, thus not needing to
take part in the study to benefit from the free evaluation
provided. The next category for refusal was unwillingness
to take part in the study, followed by logistical circum-
stances and finally health status.
Comparison between responders and non-responders
The short rejection form, albeit not available for all non-
responders, allowed the evaluation of comparable infor-
mation between those who refused and those who com-
pleted the study [see Additional File 4]. No major
differences were observed between rural non-responders
when compared to their counterparts who completed the
study, but numbers of non-responders were small in the
rural group. However, amongst the urban group, non-
responders differed from those who completed the study
in education level. More urban non-responders had com-
pleted secondary level education (70.3% vs. 56.6% in
urban responders). No differences in self reported diagno-
sis of diabetes or hypertension were seen between
response groups. In relation to migration indicators, non-
responders migrant's median age at first migration was
similar compared to responders. Both, individual socioe-
conomic reasons – studies or working reasons- and terror-
ism were listed amongst the two main reasons for
migration in both responders and non-responders.
To what extent non-response would have exerted an
impact on CVD risk in this study is less clear given the
paucity of evidence from Peru. Predicting the direction of
bias in terms of CVD risk remains difficult. A sensible
approach is to differentiate non-responders within study
groups, and then, separately, how these within-group
biases might affect the comparison of interest between
groups. Based on the results presented, it could be that in
all three groups, in within-group comparisons, a small
tendency for responders to be slightly poorer than non-
responders was observed. Therefore, when aggregated, the
overall bias in between-group comparisons might be
quite small.
Ascertainment of migration exposure
The need to confirm the ascertainment of exposure lies in
the fact that the migrant population studied has to be
comparable to the rural population, as indicative of expo-
sure to the same rural environment. Alternative ways to
confirm this can be achieved by individual's self-ascertain-
ment of their place of origin as rural or urban; by mother
tongue; and, if the pattern of migration from Ayacucho
into Lima is well established.
Confirmation of migrant status by place of origin
All participants in all study groups were asked to describe
their place of birth, and separately the type of location, i.e.
village, town or city. Nearly 80% in both rural and
migrant group reported being born in a rural area. In addi-
Table 2: Response rates in study groups
Response rate at enrolment* Response rate at completion of study** Difference
n% n %%
Rural 218/257 84.8% 201/257 78.2% 6.6%
Migrant 712/916 77.7% 589/916 64.3% 13.4%
Urban 246/433 56.8% 199/433 46.0% 10.9%
Total 1176/1606 73.2% 989/1606 61.6% 11.6%
Notes:
* Response rate at enrolment = enrolled study/attempted to contact
** Response rate at completion of study = completed study/attempted to contactBMC Cardiovascular Disorders 2009, 9:23 http://www.biomedcentral.com/1471-2261/9/23
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Study participants' flowchart, rural group Figure 2
Study participants' flowchart, rural group.
1 Moved away / no longer resident was defined as those people who no longer live in the given address and moved to another 
area or are continuously living outside the area of study (e.g. house maids and security guards working and living full-time on 
employer’s houses/properties). This definition applies for all study groups. 
2 Questionnaires completed, but no laboratory tests were done because required sample size was reached and limited funds.
RURAL GROUP 
Census 2007, >30year-old 
N = 398  
Did not want to participate   38
Moved away / no longer resident
1 40 
D e a d     1
Not contacted 
In hospital     1 
Randomly selected 
n = 298 
Attempted to contact 
n = 257 
Contacted
n = 256 
Enrolled
n = 218 
Did not complete study 
Withdrew from  study   10 
Questionnaires but no lab tests
2   6 
Moved away / no longer resident  1 
Completed study 
n = 201 BMC Cardiovascular Disorders 2009, 9:23 http://www.biomedcentral.com/1471-2261/9/23
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Study participants' flowchart, rural-to-urban migrant group Figure 3
Study participants' flowchart, rural-to-urban migrant group.
Did not want to participate   160
Moved away / no longer resident  60 
D e a d     2
O t h e r     6
[Alcoholic 3, Pregnant 2, Schizophrenic 1] 
Not contacted 
Travelling     23 
Unavailable after 3 home visits    21 
Attempted to contact
n = 916 
Randomly selected 
n = 984 
Contacted
n = 872 
Enrolled
n = 712 
Completed study 
n = 589 
Did not complete study 
Withdrew from  study   88 
Unavailable after 3 home visits    19 
Travelling     5 
Moved away / no longer resident  4 
D e a t h s     1
O t h e r     6
[Pregnant 4, Did not attend clinic 1, Incomplete 
questionnaires 1]   
RURAL-URBAN 
MIGRANT GROUP 
Census Update 2006,  
N = 1785 >30year-old BMC Cardiovascular Disorders 2009, 9:23 http://www.biomedcentral.com/1471-2261/9/23
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Study participants' flowchart, urban group Figure 4
Study participants' flowchart, urban group.
Did not want to participate   125
Moved away / no longer resident  206
D e a d     2 5
Not born in Lima      4 
O t h e r     5
[Wrong selection by birthday (3) or sex (1), Duplicate 
selection (1)] 
Not contacted 
Unavailable after 3 home visits    51 
Travelling     11 
Attempted to contact 
n = 433 
Randomly selected 
n = 673 
Contacted
n = 371 
Enrolled
n = 246 
Did not complete study 
Withdrew from  study   35 
Moved away / no longer resident  3 
Unavailable after 3 home visits    3 
Travelling     2 
O t h e r     4
[Not from Lima 1, Study finished 3] 
Completed study 
n = 199 
URBAN GROUP 
Census 2000, >30year-old 
N = 4621  BMC Cardiovascular Disorders 2009, 9:23 http://www.biomedcentral.com/1471-2261/9/23
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tion to this, the most common description of the type of
place for these groups was town and village, which coin-
cide with the rural classification self-ascertained before. In
the same vein, 81% of urban participants reported being
born in an urban area, and nearly 90% described the place
where they were born as a city or as the Capital (Lima).
Confirmation of migrant status by mother tongue
Ayacucho, the place of origin of both migrant and rural
population in this study, is largely an indigenous area
where most people speak Quechua, an ancient Peruvian
language. In Lima, the language most used is Spanish. All
study's participants were asked to name the first language
they learnt to speak. Over 85% of participants in both
rural and migrant groups reported Quechua as their
mother tongue.
Confirmation of Ayacucho-Lima migration pattern
Migration from Ayacucho into Lima, particularly fostered
by the years during terrorism, has been previously
described. It is relevant to confirm such assumption since
it could well be the case that most of migrants move to
Lima but only after spending considerable time in another
rural or urban area. This could affect the ratio of lifetime
exposure to a rural environment versus an urban one.
Amongst migrants, reported number of years living in an
urban environment was 32 years (SD ± 10.5, IQR 25–39).
Average age at first migration was 14.4 years (SD ± 8.5,
IQR 10–17). Average age when arrived into Lima was 15.5
years (SD ± 8.8, IQR 11–18). There was good correlation
between age at first migration and age when arrived into
Lima (correlation coefficient = 0.92, p = < 0.0001) thus
indicating that migrants, who were born in Ayacucho,
tend to move largely directly into Lima.
Discussion
The PERU MIGRANT Study achieved good overall
response rates, a high-degree of data completion and
included careful consideration of the potential for bias
introduced by non-responders. In addition to this, migra-
tion, the exposure of interest, was assessed using a range
of techniques. The study provides a solid framework for
research into the impact of migration on health by com-
paring migrant versus non-migrant populations.
Migration is one example of social and cultural change
[10]. Urbanisation, aided by migration, is a major feature
of today's world [5,7]. In this context, this and other
migration studies become relevant and crucial tools to
address the impact of such complex processes on health.
This background served as the basis to address to what
extent migration may have had an impact on CVD risk fac-
tors in Peruvian population.
Findings from this study will provide a much clearer pan-
orama, previously unknown, of the health profile of rural-
Distribution of refusals by gender in each study group among the 282/323 non-responders who completed a rejection form Figure 5
Distribution of refusals by gender in each study group among the 282/323 non-responders who completed a 
rejection form.BMC Cardiovascular Disorders 2009, 9:23 http://www.biomedcentral.com/1471-2261/9/23
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to-urban migrants within Peru in relation to CVD risk fac-
tors. This information in turn, will prove useful for the
understanding of CVD in Peru, and to certain extent in
other LMIC undergoing similar process. It is hoped that,
later on, the information generated in this study can
inform key policy- and decision-makers in the design and
implementation of preventative strategies.
Much epidemiology in the real world, it can be con-
tended, revolves around the quantification of known risk
factors, which are likely to interact in ways that are not
seen in other settings. This study, by defining the patterns
of differences in CVD risk that may exist in migrant and
non-migrant populations, will open the venue for the
need for further assessments to identify key determinants
for such differences.
Strengths of the study
The PERU MIGRANT Study takes advantage from one
unique context of long-term established migration in a
LMIC by studying adequate comparison groups for
migrants, in both rural and urban areas. Rural people
included those living in the same area where migrants
originated while urban people were the ones living in the
areas where migrants established. These well-defined
study groups will enable the evaluation of one group of
interest, i.e. migrants, in relation to rural and urban coun-
terparts providing a complete panorama of CVD risk pro-
file. The classification of migrants in subgroups according
to length of migration, lifetime exposure to urban envi-
ronment and age at first migration – usually not reported
in migrant studies – will expand the evaluation of the
impact of migration.
Razum [53] outlined what would be the requirements of
an "ideal" migrant cohort which includes a unique defini-
tion of "migrant" that considers duration of stay. Addi-
tionally, and ideally, participants would have to be
enrolled before they migrate, studies should include the
population of origin of immigrants and studies should be
based on individual data collected over time to under-
stand the determinants of the relation between migration
Distribution of refusals by age in each study group among the 282/323 non-responders who completed a rejection form Figure 6
Distribution of refusals by age in each study group among the 282/323 non-responders who completed a rejec-
tion form.BMC Cardiovascular Disorders 2009, 9:23 http://www.biomedcentral.com/1471-2261/9/23
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Table 3: Reasons for refusing participation in the study
Rural Migrant Urban Total Proportion*
nn n n %
Access to health care
Total 0 46 46 92 32.6%
Have social security insurance 0 26 33 59 20.9%
Have access to medical check-ups if wanted/needed 0 20 13 33 11.7%
Unwillingness to participate
Total 0 43 24 67 23.8%
Distrust (e.g. disclosure of personal details, signature) 0 13 12 25 8.9%
"Do not want to participate" statement 0 11 7 18 6.4%
Did not want blood samples to be taken 0 12 4 16 5.7%
Negativism from relative of selected participant 0 7 1 8 2.8%
Logistical
Total 1 17 32 50 17.7%
Time constraints due to working 0 6 12 18 6.4%
Time constraints, unspecified 0 5 13 18 6.4%
Travelling 0 4 1 5 1.8%
Other** 1 2 6 9 3.2%
Health status
Total 0 16 14 30 10.6%
Recent laboratory test done, no results provided 0 9 5 14 5.0%
Sickness, non-CVD 0 2 5 7 2.5%
Recent laboratory test done, negative for CVD risk factors 0 1 3 4 1.4%
Sickness, unspecified 0 3 0 3 1.1%
Sickness, CVD*** 0 1 1 2 0.7%
Notes: Reasons for refusal shown in this table are not mutually exclusive and were aggregated using four categories. The same individual could have 
answer more than one option.
* This proportion is calculated using the total of responses as numerator and the total of non-responders (n = 282) as denominator
** Other category included the following reasons: 4 religious beliefs or ideologies, 3 fieldwork mistakes with appointments, 1 pregnant, 1 do not live 
permanently in the area
*** Sickness CVD included 1 case with diagnosed diabetes and 1 case with diagnosed hypercholesterolaemia. In both cases treatment status was not 
specified.BMC Cardiovascular Disorders 2009, 9:23 http://www.biomedcentral.com/1471-2261/9/23
Page 14 of 16
(page number not for citation purposes)
and health [53]. As suggested by Razum [53], the PERU
MIGRANT study considers duration of stay in an urban
area enabling the assessment of long-term exposures to an
urban environment. This study have the added value of
evaluating full CVD risk factors, including blood traits, in
a context of increased urbanization that closely resembles
today's LMIC. The standard definitions used will enable
comparability of data with other resources from LMIC.
It is also worth noticing that the response rates observed
in the present study working in poor urban and rural com-
munities are not so different from those of larger studies
conducted in developed countries. To name a few, the UK
National Women's Health Study had a response rate of
49% for Stage 1 (a total of 26,050 questionnaires were
returned in this stage) and 73% for the more targeted
Stage 2 [54]. The British Regional Heart Study 1975–2004
response rate was 78% [55-57]. The British Women's
Heart and Health Study had a 59.8% response rate (a total
of 4286 women of the 7173 invited) [58,59]. In the US,
the Atherosclerosis Risk in Communities Study' response
rate ranged from 46% to 67% in the communities studied
[60]. Therefore, the response rates observed in this study
were within or above the range of response rates of inter-
nationally recognized well-conducted observational stud-
ies.
Limitations of this study
Selection bias remains an important concern in migrant
studies [53] and this study may not be free from this lim-
itation. This is basically a concern with population
denominators whereby migrants studied as a proportion
of those who remain in their place of origin or as a pro-
portion of total migrants are not generally known.
Due to the unique circumstances of the Peruvian context,
where a forced migration process occurred, it would be
expected that a wide diversity and majority of people from
the rural part of Ayacucho had strong pressures to migrate,
and not only the better-off – biologically and socioeco-
nomically – sectors of this population. Rural and urban
control groups were defined a priory to match the rural
area of origin of most migrants as well as their urban des-
tination. In this sense, although unavoidable, this study
has benefited from a less extreme type of selection bias
amongst the migrant populations in comparison to other
studies of the same nature.
One major determinant of CVD risk, diet, has not been
included in this study. Diet has an impact on a number of
specific traits to be analyzed in this study, including obes-
ity-related risk factors and lipid markers. These two factors
are important ones for any study of CVD risk. However,
this study was set out to find out whether or not differ-
ences exist in a number of risk factors and will not be
capable, limited by its design, to explain but to postulate
why these differences may occur.
Conclusion
The PERU MIGRANT Study achieved good overall
response rates, a high-degree of data completion and
included careful consideration of the potential for bias
introduced by non-responders. In addition to this, migra-
tion, the exposure of interest, was assessed using a range
of techniques. The study provides a solid framework for
research into the impact of migration on health by com-
paring migrant versus non-migrant populations in a low-
income setting.
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